Breaking News

INCOG BioPharma Services Announces Expansion Projects for 2025

Plans include the expansion of its facilities, scaling up of core filling capabilities, adding new finishing capabilities, and strategic hiring.

Author Image

By: Charlie Sternberg

Associate Editor

INCOG BioPharma Services, a contract development and manufacturing organization (CDMO) specializing in sterile injectable biopharmaceuticals, has announced strategic expansion projects for 2025. These efforts include the physical expansion of its Fishers-based facilities, scaling up of core filling capabilities, adding significant new finishing capabilities, and strategic hiring focused on attracting top-tier talent. Last September, the company broke ground on its second building, adjacent an...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters